U.S. flag

An official website of the United States government

GRCh38/hg38 21q22.3(chr21:43675516-43976023)x3 AND See cases

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Aug 12, 2011
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000052830.5

Allele description [Variation Report for GRCh38/hg38 21q22.3(chr21:43675516-43976023)x3]

GRCh38/hg38 21q22.3(chr21:43675516-43976023)x3

Genes:
  • AGPAT3:1-acylglycerol-3-phosphate O-acyltransferase 3 [Gene - OMIM - HGNC]
  • LOC130066784:ATAC-STARR-seq lymphoblastoid active region 18546 [Gene]
  • LOC130066787:ATAC-STARR-seq lymphoblastoid active region 18547 [Gene]
  • LOC130066790:ATAC-STARR-seq lymphoblastoid active region 18548 [Gene]
  • LOC130066792:ATAC-STARR-seq lymphoblastoid active region 18549 [Gene]
  • LOC130066793:ATAC-STARR-seq lymphoblastoid active region 18550 [Gene]
  • LOC130066794:ATAC-STARR-seq lymphoblastoid active region 18551 [Gene]
  • LOC130066795:ATAC-STARR-seq lymphoblastoid active region 18552 [Gene]
  • LOC130066799:ATAC-STARR-seq lymphoblastoid active region 18553 [Gene]
  • LOC130066800:ATAC-STARR-seq lymphoblastoid active region 18554 [Gene]
  • LOC130066801:ATAC-STARR-seq lymphoblastoid active region 18555 [Gene]
  • LOC130066803:ATAC-STARR-seq lymphoblastoid active region 18558 [Gene]
  • LOC130066783:ATAC-STARR-seq lymphoblastoid silent region 13363 [Gene]
  • LOC130066785:ATAC-STARR-seq lymphoblastoid silent region 13364 [Gene]
  • LOC130066786:ATAC-STARR-seq lymphoblastoid silent region 13365 [Gene]
  • LOC130066788:ATAC-STARR-seq lymphoblastoid silent region 13368 [Gene]
  • LOC130066789:ATAC-STARR-seq lymphoblastoid silent region 13369 [Gene]
  • LOC130066791:ATAC-STARR-seq lymphoblastoid silent region 13370 [Gene]
  • LOC130066796:ATAC-STARR-seq lymphoblastoid silent region 13371 [Gene]
  • LOC130066797:ATAC-STARR-seq lymphoblastoid silent region 13372 [Gene]
  • LOC130066798:ATAC-STARR-seq lymphoblastoid silent region 13373 [Gene]
  • LOC130066802:ATAC-STARR-seq lymphoblastoid silent region 13374 [Gene]
  • LOC116309124:CRISPRi-validated cis-regulatory element chr21.1179 [Gene]
  • LOC108254685:PDXK-CSTB intergenic CAGE-defined low expression enhancer [Gene]
  • LOC108281139:RRP1B-PDXK intergenic CAGE-defined mid-level expression enhancer [Gene]
  • LOC121853032:Sharpr-MPRA regulatory region 2423 [Gene]
  • AATBC:apoptosis associated transcript in bladder cancer [Gene - HGNC]
  • LOC109029533:cystatin B upstream repeat instability region [Gene]
  • CSTB:cystatin B [Gene - OMIM - HGNC]
  • PDXK:pyridoxal kinase [Gene - OMIM - HGNC]
  • RRP1:ribosomal RNA processing 1 [Gene - OMIM - HGNC]
  • RRP1B:ribosomal RNA processing 1B [Gene - OMIM - HGNC]
Variant type:
copy number gain
Cytogenetic location:
21q22.3
Genomic location:
Preferred name:
GRCh38/hg38 21q22.3(chr21:43675516-43976023)x3
HGVS:
  • NC_000021.9:g.(?_43675516)_(43976023_?)dup
  • NC_000021.7:g.(?_43919825)_(44220332_?)dup
  • NC_000021.8:g.(?_45095397)_(45395904_?)dup
Links:
dbVar: nssv581062; dbVar: nsv531545
Observations:
1

Condition(s)

Name:
See cases [See the Variation display for details]
Identifiers:

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000080184GeneDx
criteria provided, single submitter

(Kaminsky et al. (Genet Med. 2011))
Uncertain significance
(Aug 12, 2011)
not providedclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providednot providedyes1not providednot providednot providednot providedclinical testing

Citations

PubMed

An evidence-based approach to establish the functional and clinical significance of copy number variants in intellectual and developmental disabilities.

Kaminsky EB, Kaul V, Paschall J, Church DM, Bunke B, Kunig D, Moreno-De-Luca D, Moreno-De-Luca A, Mulle JG, Warren ST, Richard G, Compton JG, Fuller AE, Gliem TJ, Huang S, Collinson MN, Beal SJ, Ackley T, Pickering DL, Golden DM, Aston E, Whitby H, et al.

Genet Med. 2011 Sep;13(9):777-84. doi: 10.1097/GIM.0b013e31822c79f9.

PubMed [citation]
PMID:
21844811
PMCID:
PMC3661946

Details of each submission

From GeneDx, SCV000080184.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1not providedyesnot providednot providedDiscovery1not providednot providednot provided

Last Updated: Oct 14, 2023